Antimicrobial therapy of febrile complications after high-dose chemo-/radiotherapy and autologous hematopoietic stem cell transplantation - Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Annals of Hematology

Volumn 82, Issue SUPPL. 2, 2003, Pages

  Bertz, Hartmut ^a   Auner, Holger W ^b   Weissinger, Florian ^c   Salweder, Hans Jürgen ^d   Einsele, Hermann ^e   Egerer, Gerlinde ^f   Sandherr, Michael ^g   Schüttrumpf, Silke ^h   Südhoff, Thomas ⁱ   Maschmeyer, Georg ^j  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d ASKLEPIOS KLINIK ALTONA   (Germany)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^g KLINIKUM AUGSBURG   (Germany)

^h UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

ⁱ ST JOSEF HOSPITAL   (Germany)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

more..

Author keywords

Hematopoietic stem cell transplantation; High dose chemotherapy; Neutropenia

Indexed keywords

ACICLOVIR; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CASPOFUNGIN; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; COTRIMOXAZOLE; FLUCONAZOLE; GANCICLOVIR; ITRACONAZOLE; MACROLIDE; METRONIDAZOLE; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RECOMBINANT GROWTH FACTOR; TEICOPLANIN; UNINDEXED DRUG; VANCOMYCIN; VORICONAZOLE;

ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CATHETER INFECTION; DIAGNOSTIC TEST; DRUG EFFICACY; DRUG MEGADOSE; EMPIRICISM; EPIDEMIOLOGICAL DATA; FEBRILE NEUTROPENIA; GASTROINTESTINAL INFECTION; GERMANY; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; GRAM POSITIVE COCCI; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HUMAN; LUNG INFILTRATE; LUNG MYCOSIS; MEDICAL SOCIETY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUCOSA INFLAMMATION; MYCOSIS; NONHUMAN; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN INFECTION;

ANTI-BACTERIAL AGENTS; DRUG THERAPY; FEVER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; RADIOTHERAPY; TRANSPLANTATION, AUTOLOGOUS;

EID: 0142062504     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-003-0771-5     Document Type: Article

References (51)

1. Aksu G, Ruhi M Z, Akan H, Bengisun S, Ustun C, Arslan O, Ozenci H (2001). Aerobic bacterial and fungal infections in peripheral blood stem cell transplants. Bone Marrow Transplant 27:201-205
2. Auner HW, Sill H, Mulabecirovic A, Linkesch W, Krause R (2002) Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma. Ann Hematol 81:374-377
3. Ayash LJ, Elias A, Schwartz G, Wheeler C, Ibrahim C, Teicher BA, Reich E, Warren D, Lynch C, Richardson P, Schnipper L, Frei E III, K Antman (1996) Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin. J Clin Oncol 14:2984-2992
4. Azoulay E, Alberti C, Bornstain C, Leleu G, Moreau D, Recher C, Chevret S, Le Gall JR, Brochard L, Schlemmer B (2001) Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit Care Med 29:519-525
5. Bilgrami S, Feingold JM, Dorsky D, Edwards RL, Clive J Tutschla PJ (1998) Streptococcus viridans bacteremia following autologous peripheral stem cell transplantation. Bone Marrow Transplant 21:591-595
6. Bilgrami S, Feingold JM, Dorsky D, Edwards RL, Bona RD, Khan AM, Rdriguez-Pinero F, Clive J Tutschla PJ (1999) Incidence an outcome of clostridium difficile infection following autologous peripheral stem cell transplantation. Bone Marrow Transplant 23:1039-1042
7. Bitran JD, Samuels B, Klein L, Hanauer S, Johnson L, Martinec J, Harris E, Kempler J, White W (1996) Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer. Bone Marrow Transplant 17:157-162
8. Blijlevens NM, Donnelly JP, de Pauw BE (2001) Empirical therapy of febrile neutropenic patients with mucositis: challenge of risk-based therapy. Clin Microbiol Infect 7 (Suppl 4):47-52
9. Caillot D, Casasnovas O, Bernard A, Couaillier JF, Durand C, Cuisenier B, Solary E, Piard F, Petrella T, Bonnin A, Couillault G, Dumas M, Guy H (2001) Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 15:139-147
10. Celebi H, Akan H, Akca, layan E, Ustun C, Arat M (2000) Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies. Bone Marrow Transplant 26:211-214
11. Cordonnier C, Chevret S, Legrand M, Rafi H, Dhedin N, Lehmann B, Bassompierre F, Gluckman E; GREFIG Study Group (2003) Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial. Ann Intern Med 139:8-18
12. Cornely OA, Hiddemann W, Link H, Maschmeyer G, Glass B, Buchheidt D, Wilhelm M, Büchner TH, Lipp TH, Haas R, Heinemann V, Helmerking M, Adam D for the study group of the PEG (1997) Interventional antimicrobial therapy in febrile neutropenic patients - Paul Ehrlich Society for Chemotherapy (PEG) study II. Ann Hematol 74 (Suppl I):A51
13. Engelhard D, Cordonnier C, Shaw PJ, Parkalli T, Guenther C, Martino R, Dekker AW, Prentice HG, Gustavsson A, Nurnberger W, Ljungman P The Infectious Disease Working Party of the European Bone Marrow Transplantation (IDWP-EBMT) (2002) Early and late invasive pneumococcal infection following stem cell transplantation: an European Bone Marrow Transplantation survey. Br J Haematol 117:444-450
14. Erjavec Z, de Vries-Hospers HG, Laseur M, Halie RM, Daenen S (2000) A prospective, rando-mized, double-blinded, placebo-controlled trial of empirical teicoplanin in febrile neutropenia with persis-tent fever after imipenem monotherapy. J Antimicrob Chemother 45:843-849
15. Fassas AB-T, Bolanos-Meade J, Buddharaju L N, Rapoport A, Cottler-Fox M, Chen T, Lovchik J C, Cross A, Tricot G (2001) Cytomegalovirus infection and non-neutropenic fever after autologous stem cell transplantation: High rates of reactivation in patients with multiple myeloma and lymphoma. Br J Haematol 112:237-241
16. Feld R (1999) Vancomycin as part of initial empirical antibiotic therapy for febrile neutropenia in patients with cancer: pros and cons. Clin Infect Dis 29:503-507
17. Fujii K, Aoyama M, Shinagawa K, Amtsuo K, Takenaka K, Ikeda K, Kojima K, Ishimaru F, Kiura K, Ueoka H, Niiya K, Tanimoto M, Harad M (2002) Risk of neutropenic fever and early infectious complications after autologous peripheral stem cell transplantation for malignant diseases. Int J Hematol 76:186-191
18. Gilbert C, Meisenberg B, Vredenburgh J, Ross M, Hussein A, Perfect J, Peters WP (1994) Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support. J Clin Oncol 12:1005-1011
19. Glenn J, Cotton D, Wesley R, Pizzo P (1988) Anorectal infections in patients with malignant diseases. Rev Infect Dis 10:42-52
20. Hilbert G, Gruson D, Vargas F, Valentino R, Gbikpi-Benissan G, Dupon M, Reiffers J, Cardinaud JP. (2001) Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 344:481-487
21. Hughes WT, Pizzo PA, Wade JC, Armstrong D, Webb CD, Young LS (1992) Evaluation of new anti-infective drugs for the treatment of febrile episodes in neutropenic patients. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis 15 (Suppl 1): S206-S215
22. Hughes WT, Armstrong D, Bodey GP, Brown AE, Edwards JE, Feld R, P Pizzo P, Rolston KVI, Shenep JL, Young LS (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 34:730-751
23. Immunocompromised host society consensus panel (Pizzo PA, Armstrong D, Bodey GP, De Pauw BE, Feld R, Glauser M, Gaya H, Karp J, Klastersky J, Todeschini G, Verhoef J, Wade J, Young LS, Remington J) (1990) The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient: report of a consensus panel for the Immunocompromised Host Society. J Infect Dis 161:397-401
24. Ketterer N, Espinouse D, Chomarat M, Dumontet C, Moullet I, Rieux C, Neidhardt-Berard EM, Bouafia F, Coiffier B, Salles G (1999) Infections following peripheral blood progenitor cell transplantation for lympho-proliferative malignancies: Aetiology and potential risk factors. Am J Med 106:191-197
25. Kolbe K, Domkin D, Derigs HG, Bhakdi S, Huber C, Aulitzky WE (1996) Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation. Bone Marrow Transplant 19:143-147
26. Koya R, Andersen J, Fernandez H, Goodman M, Spector N, Smith R, Hanlon J, Cassileth P A (1998) Analysis of the value of empiric vancomycin administration in febrile neutropenia occurring after autologous peripheral blood stem cell transplants. Bone Marrow Transplant 21:923-926
27. Krueger W, Ruessmann B, Kroeger N, Salomon C, Ekopf N, Elsner H-A, Kaulfers P-M, Mack D, Fuchs N, Duerken M, Kabisch H, Erttmann R, Zander A R (1999) Early infections in patients undergoing bone marrow or blood stem cell transplantation - A 7 year single centre investigation of 409 cases. Bone Marrow Transplant 23:589-597
28. Krüger WH, Salomon C, Rüssmann B, Stockschläder M, Grimm J, Kröger N, Dewit M, Bieling P, Horstmann M, Fiedler M, Kabisch H, Erttmann R, Zander AR (1997) Early infections in bone marrow and blood stem cell transplantation. Bone Marrow Transplant 19 (Suppl 1 ):S166
29. Larrea L, Jarque IO, De la Rubia J, Belloch L, Arnao M, Cervera J, Solves P, Sempere A, Jimenez C, Sanz GF, Martin G, Martínez J, Sanz MA (1997) Early infections after autologous blood stem cell transplantation: a study of 145 patients. Bone Marrow Transplant 19 (Suppl 1):S166
30. Larsson K, Bjorkstrand B, Ljungman P (1998) Faster engraftment but no reduction in infectious complications after peripheral blood stem cell transplantation compared to autologous bone marrow transplantation. Support Care Cancer 6:378-383
31. Link H, Hiddemann W, Maschmeyer G, Buchheidt D, Glass B, Cornely O, Wilhelm M, Helmerking M, Adam D and the PEG study group (1997) Antimicrobial therapy in neutropenic patients with unexplained fever, PEG Study II. Proc Intersc Conf Antimicrob Agents Chemother 37:372
32. Mahendra P, Jacobson SK, Ager S, Bass G, Barker P, Johnson D, Baglin TP, Marcus RE (1996) Short-course intravenous antibiotics with oral quinolone prophylaxis in the treatment of neutropenic fever in autologous bone marrow or peripheral blood progenitor cell transplant recipients. Acta Haematol 96:64-67
33. Meisenberg BR, Miller WE, McMillan R, Callaghan M, Sloan C, Brehm T, Kosty MP, Kroener J, Longmire R, Saven A, Piro LD (1997) Outpatient high-dose chemotherapy with autologous stem-cell rescue for hematologic and nonhematologic malignancies. J Clin Oncol 15:11-17
34. Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS, Craven DE; Infectious Diseases Society of America; American College of Critical Care Medicine; Society for Healthcare Epidemiology of America (2001) Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32:1249-1272
35. Mossad SB, Longworth DL, Goormastic M, Serkey JM, Keys TF, Bolwell BJ (1996) Early infectious complications in autologous bone marrow transplantation: a review of 219 patients. Bone Marrow Transplant 18:265-271
36. Ninin E, Milpied N, Moreau P, Andre-Richet B, Morineau N, Mahe B, Vigier M, Imbert BM, Morin O, Harousseau JL, Richet H (2001) Longitudonal study of bacterial, viral and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis 33:41-47
37. Nosanchuk JD, Sepkowitz KA, Pearse RN, White MH, Nimer SD, Armstrong D (1996): Infectious complications of autologous bone marrow and peripheral stem cell transplantation for refractory leukemia and lymphoma. Bone Marrow Transplant 18:355-359
38. Nucci M, Landau M, Silveira F, Spector N, Pulcheri W (2001) Application of the IDSA guidelines for the use of antimicrobial agents in neutropenic patients: impact on reducing the use of glycopeptides. Infect Control Hosp Epidem 22:651-653
39. Ozer H, Armitage JO, Bennett CL, Crawford J, Demetri GD, Pizzo PA, Schiffer CA, Smith TJ, Somlo G, Wade JC, Wade JL 3rd, Winn RJ, Wozniak AJ, Somerfield MR (2000) American Society of Clinical Oncology. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol 18:3558-3585
40. Perez-Simon JA, Martin A, Caballero D, Corral M, Nieto MJ, Gonzalez M, Vazquez L, Lopez-Berges C, Canizo MC, Mateos MV, Orfao A, San Miguel JF (1999) Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 24:1279-1283
41. Reich G, Mapara MY, Reichardt P, Dorken B, Maschmeyer G (2001) Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors. Bone Marrow Transplant 27:525-529
42. Rolston KV, Bodey GP (1993) Diagnosis and management of perianal and perirectal infection in the granulocytopenic patient. Curr Clin Top Infect Dis 13:164-171
43. Rolston KV, Dholakia N, Rodriguez S, Rubenstein EB (1995) Nature and outcome of febrile episodes in patients with pancreatic and hepatobiliary cancer. Support Care Cancer 3:414-417
44. Salazar R, Sola C, Maroto P, Tabernero J M, Brunet J, Verger G, Valenti V, Cancelas J A, Ojeda B, Mendoza L, Rodriguez M, Montesinos J, Lopez-Lopez J J (1999) Infectious complications in 126 patients treated with high-dose chemotherapy and autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 23: 27-33
45. Salutari P, Sica S, Bernardini A, Laurenti L, Chiusolo P, Di Mario A, Sefranil R, Leone G (1998) Incidence of sepsis after peripheral blood progenitor cells transplant: analysis of 66 consecutive onco-hematological patients. Leuk Lymphoma 30: 193-197
46. Scheid C, Draube A, Reiser M, Schulz A, Chemnitz J, Nelles S, Fuchs M, Winter S, Wickramanayake PD, Diehl V, Sohngen D (1999) Using at least 5×10(6)/kg CD34+ cells for autologous stem cell transplantation significantly reduces febrile complications and use of antibiotics after transplantation. Bone Marrow Transplant 23:1177-1181
47. Sevilla J, Hernandez-Maraver D, Aguado MJ, Ojeda E, Morado M, Hernandez-Navarro F (2001) Autologous peripheral blood stem cell transplant in patients previously diagnosed with invasive aspergil-losis. Ann Hematol 80:456-459
48. Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, Hayden V, Eilers J, Epstein JB, LeVeque FG, Miller C, Peterson DE, Schubert MM, Spijkervet FK, Horowitz M (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19:2201-2205
49. Viscoli C, Castagnola E (2002) Treatment of febrile neutropenia: what is new? Curr Opin Infect Dis 15:377-382
50. Yeh SP, Chiu CF, Lo WJ, Lin CL, Hsueh CT, Liao YM, Shen YC (2003) Low infectious morbidity in patients with heavily pretreated hematological malignancies receiving autologous peripheral blood stem cell transplantation without antimicrobial prophylaxis. Ann Hematol 82:24-29
51. Weaver CH, Schwartzberg LS, Hainsworth J, Greco FA, Li W, Buckner CD, West WH (1997) Treatment-related mortality in 1000 consecutive patients receiving high-dose chemotherapy and peripheral blood progenitor cell transplantation in community cancer centers. Bone Marrow Transplant 19:671-678